Roberta Olcese

Dr. Roberta Olcese


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2021 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
Martina VottoMartina Votto
Martina Votto
MFMaria De Filippo
Maria De Filippo
LCLucia Caminiti
Lucia Caminiti
FCFrancesco Carella
Francesco Carella
GCGiovanna de Castro
Giovanna de Castro
SBSalvatore Barberi
Salvatore Barberi

24 April 2023 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
Maria Angela ToscaMaria Angela Tosca
Maria Angela Tosca
Irene SchiavettiIrene Schiavetti
Irene Schiavetti
RORoberta Olcese
Roberta Olcese
CTChiara Trincianti
Chiara Trincianti
Giorgio CiprandiGiorgio Ciprandi
Giorgio Ciprandi
Background. Cow’s milk allergy (CMA) is the most common food allergy in early childhood. Children with CMA require a precise and punctual diagnosis. Oral food challenge (OFC) is the gold-standard procedure for diagnosing allergies, but it is laborious and requires a particular setting. The aim of the study was to identify the cutoff value of serum allergen-specific IgE values able to predict a positive response to OFC. Methods. Children with suspected CMA performed OFC with cow’s milk (CM) or derivatives. Total IgE and specific IgE to raw CM, α-lactalbumin, β-lactoglobulin, and casein were measured. Results. Seventy-two children performed OFC, and 30 (41.6%) had a positive response. The significant predictive factors were sensitization to raw CM extract ( ), α-lactalbumin ( ), β-lactoglobulin ( ), and casein ( ). The cutoff was, respectively: 5.13 kUA/L for raw CM, 1.47 for α-lactalbumin, 1.35 for β-lactoglobulin, and 4.87 for casein. Conclusions. This study allowed us to define a set of cutoff values for CM protein-specific IgE. However, these cutoffs should be interpreted not as a diagnostic tool for CMA but only predictive of response to OFC in a specific territory. Thus, the practical message may be that a value above the cutoff allows a good approximation to identify children to be started on OFC.

30 November 2022 in Children
Verified
Journal Article
Open access
PDF file
Maria Angela ToscaMaria Angela Tosca
Maria Angela Tosca
RORoberta Olcese
Roberta Olcese
GMGuido Marinelli
Guido Marinelli
Irene SchiavettiIrene Schiavetti
Irene Schiavetti
Giorgio CiprandiGiorgio Ciprandi
Giorgio Ciprandi
Cow milk allergy (CMA) is a prevalent disease in childhood. Natural history is usually favorable as CMA can disappear by school age in many subjects. Diagnosis corresponds to treatment, as an elimination diet is a solution. However, cow’s milk (CM) is real food, hardly replaceable. Thus, CM reintroduction represents a demanding challenge in clinical practice. The induction of CM tolerance could be achievable using oral immunotherapy (OIT), such as the administration of increasing milk quantities until reaching tolerance. However, the OIT schedule and procedure need to be better standardized, and performance may vary widely. Therefore, the present study reports the practical experience of a third-level pediatric allergy center in managing children with CMA and submitting them to OIT. OFC and OIT are relatively safe procedures as the reaction rate is low. Almost two-thirds of the OIT subjects tolerated CM. Reactions were associated with high IgE levels. Therefore, the present experience, developed by a qualified center, may suggest and propose a practical approach for managing children with CMA. After the initial workup, including a thorough history, physical examination, and laboratory tests, OFC and, when indicated, OIT could be performed in most children with CMA.

15 September 2020
Verified
Journal Article
Open access
Maria Angela ToscaMaria Angela Tosca
Maria Angela Tosca
ALAmelia Licari
Amelia Licari
RORoberta Olcese
Roberta Olcese
Riccardo CastagnoliRiccardo Castagnoli
Riccardo Castagnoli
AMAlessia Marseglia
Alessia Marseglia
Giorgio CiprandiGiorgio Ciprandi
Giorgio Ciprandi
To date, the only disease-modifying treatment strategy for allergic rhinitis and asthma is allergen immunotherapy (AIT). There is evidence that AIT improves allergic rhinitis and asthma, such as reducing symptom severity and medication use and improving of quality of life, with a long-lasting effect after the end of the course. The recent clinical trials evidenced AIT effectiveness and safety in allergic asthma. Consequently, the current version of the GINA (Global Initiative for Asthma) guidelines recommend AIT as an add-on therapy for asthma. There is also evidence that AIT may exert preventive activity on the possible progression from allergic rhinitis to asthma in children and the onset of new sensitizations. (www.actabiomedica.it)

31 August 2022
Verified
Journal Article
Open access
Maria Angela ToscaMaria Angela Tosca
Maria Angela Tosca
Irene SchiavettiIrene Schiavetti
Irene Schiavetti
RORoberta Olcese
Roberta Olcese
MGMichele Miraglia del Giudice
Michele Miraglia del Giudice
Giorgio CiprandiGiorgio Ciprandi
Giorgio Ciprandi
Background Reversible bronchial obstruction characterizes asthma. Spirometry is the gold standard to assess airflow, and FEV1 is the most reliable parameter in this regard. However, many children with asthma have FEV1 within the normal range despite uncontrolled asthma and worsening. Therefore, FEF25-75 has been proposed as a valuable marker of early airflow impairment. This study aimed at investigating FEF25-75 in a cohort of children with newly diagnosed asthma. Methods 381 children (122 females, mean age 11.6 years) were consecutively visited and had a new asthma diagnosis. In addition, Spirometry, type-2 phenotyping, asthma control assessment, and ACT were performed. Results 72 (18.9%) asthmatic children had impaired FEF25-75, such as <65% of predicted. Low FEF25-75 was associated with lower FVC and FEV1/FVC values (OR 1.11 and 1.32, respectively). Children with normal FEV1 but impaired FEF25-75 had more frequently uncontrolled asthma (15.8% vs. 32.4%) than children with both parameters within the normal range. Conclusions FEF25-75 deserves adequate and careful consideration in children with asthma, and the presence of impaired FEF25-75 values suggests a more compelling approach.